Pfizer Management
Management criteria checks 3/4
Pfizer's CEO is Albert Bourla, appointed in Jan 2019, has a tenure of 5.25 years. total yearly compensation is $21.56M, comprised of 8.3% salary and 91.7% bonuses, including company stock and options. directly owns 0.006% of the company’s shares, worth $8.54M. The average tenure of the management team and the board of directors is 5.3 years and 7.2 years respectively.
Key information
Albert Bourla
Chief executive officer
US$21.6m
Total compensation
| CEO salary percentage | 8.3% |
| CEO tenure | 5.3yrs |
| CEO ownership | 0.006% |
| Management average tenure | 5.3yrs |
| Board average tenure | 7.2yrs |
Recent management updates
Recent updates
Pfizer: The Market Is Wrong
Apr 11Pfizer: Attractive Valuation And A Strong Pipeline Mitigate Patent Cliff Concerns
Mar 18Pfizer: A Strong Buy Trading Below A 10 P/E Ratio
Mar 08Pfizer: A Value Trap, Not A Bargain
Feb 28Pfizer: Turnaround Is Gaining Momentum
Feb 21Is Pfizer (NYSE:PFE) A Risky Investment?
Feb 21
Pfizer Is A Great Investment Over The Next Decade; Buy
Feb 09Pfizer: Reviewing Q4 Earnings, FY24 Guidance - Why I Disagree With The Market
Jan 31Why I'm Avoiding 6%-Yielding Pfizer Stock
Jan 23Pfizer Is Part Of The 2024 Healthcare Sector Rally Cohort
Jan 12Pfizer's (NYSE:PFE) Dividend Will Be Increased To $0.42
Jan 10Pfizer: If You Missed The Pandemic Entry, Here's Another Chance
Jan 03Pfizer: Why I Am Buying The 5.92% Yield After The 2.4% Dividend Increase
Dec 26Eli Lilly Looks Overvalued, Buy Pfizer Instead
Dec 19Pfizer's (NYSE:PFE) Shareholders Will Receive A Bigger Dividend Than Last Year
Dec 18CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | US$22m | US$2m | US$2b |
| Oct 01 2023 | n/a | n/a | US$10b |
| Jul 02 2023 | n/a | n/a | US$21b |
| Apr 02 2023 | n/a | n/a | US$29b |
| Dec 31 2022 | US$33m | US$2m | US$31b |
| Oct 02 2022 | n/a | n/a | US$30b |
| Jul 03 2022 | n/a | n/a | US$29b |
| Apr 03 2022 | n/a | n/a | US$25b |
| Dec 31 2021 | US$24m | US$2m | US$22b |
| Oct 03 2021 | n/a | n/a | US$19b |
| Jul 04 2021 | n/a | n/a | US$12b |
| Apr 04 2021 | n/a | n/a | US$9b |
| Dec 31 2020 | US$21m | US$2m | US$7b |
| Sep 27 2020 | n/a | n/a | US$212m |
| Jun 28 2020 | n/a | n/a | US$7b |
| Mar 29 2020 | n/a | n/a | US$9b |
| Dec 31 2019 | US$18m | US$2m | US$11b |
| Sep 29 2019 | n/a | n/a | US$16b |
| Jun 30 2019 | n/a | n/a | US$13b |
| Mar 31 2019 | n/a | n/a | US$11b |
| Dec 31 2018 | US$10m | US$1m | US$4b |
| Sep 30 2018 | n/a | n/a | US$24b |
| Jul 01 2018 | n/a | n/a | US$23b |
| Apr 01 2018 | n/a | n/a | US$22b |
| Dec 31 2017 | US$9m | US$1m | US$21b |
Compensation vs Market: Albert's total compensation ($USD21.56M) is above average for companies of similar size in the US market ($USD13.37M).
Compensation vs Earnings: Albert's compensation has been consistent with company performance over the past year.
CEO
Albert Bourla (61 yo)
5.3yrs
Tenure
US$21,562,064
Compensation
Dr. Albert Bourla, DVM, Ph.D. serves as the Chief Executive Officer of Pfizer Inc. since January 1, 2019 and serves as its Chairman and director of the Board since January 2020 and had been its Executive D...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board & CEO | 5.3yrs | US$21.56m | 0.0059% $ 8.5m | |
| Chief Financial Officer & Executive VP | 1.9yrs | US$5.28m | 0.00029% $ 421.9k | |
| Chief Scientific Officer and President of Research & Development | 5.3yrs | US$8.86m | 0.0057% $ 8.3m | |
| Executive VP & General Counsel | 10.3yrs | US$5.48m | 0.0026% $ 3.8m | |
| Executive VP & Chief U.S. Commercial Officer | 2.7yrs | US$5.42m | 0.000010% $ 14.5k | |
| Senior VP | 4.1yrs | no data | 0.00024% $ 349.1k | |
| Executive VP and Chief Digital & Technology Officer | 5.3yrs | no data | 0.00063% $ 916.5k | |
| Chief Investor Relations Officer | no data | no data | no data | |
| Executive VP and Chief Compliance | 10.3yrs | no data | 0.0018% $ 2.7m | |
| Global Chief Marketing Officer | 1.6yrs | no data | no data | |
| Chief People Experience Officer & Executive VP | 3.8yrs | no data | 0.00063% $ 916.5k | |
| Executive VP & Chief Corporate Affairs Officer | 16.2yrs | no data | 0.0029% $ 4.2m |
5.3yrs
Average Tenure
57.5yo
Average Age
Experienced Management: PFE's management team is seasoned and experienced (5.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board & CEO | 4.3yrs | US$21.56m | 0.0059% $ 8.5m | |
| Lead Independent Director | 10.6yrs | US$430.00k | no data | |
| Independent Director | 7.2yrs | US$380.00k | 0.00023% $ 334.6k | |
| Independent Director | 16.6yrs | US$410.00k | 0.00018% $ 261.8k | |
| Independent Director | 9.8yrs | US$390.00k | 0.000060% $ 87.3k | |
| Member of Emerging Markets Advisory Board | no data | no data | no data | |
| Independent Director | 4.1yrs | US$363.00k | no data | |
| Independent Director | 6.1yrs | US$391.40k | no data | |
| Independent Director | 4.2yrs | US$380.00k | no data | |
| Independent Director | 4.8yrs | US$417.20k | 0.00016% $ 232.8k | |
| Independent Director | 8.8yrs | US$390.00k | no data | |
| Independent Director | 12.3yrs | US$410.00k | no data |
7.2yrs
Average Tenure
64.5yo
Average Age
Experienced Board: PFE's board of directors are considered experienced (7.2 years average tenure).